腮腺良恶性肿瘤鉴别诊断的MRI征象分析
[Abstract]:Objective: to analyze the MRI features of parotid benign and malignant tumors, to compare the MRI signs used to differentiate benign and malignant parotid tumors, and to investigate the supportive MRI signs of some parotid tumors. Materials and methods: the clinical and imaging data of 165 cases of parotid tumors confirmed by pathology from January 2008 to December 2012 were analyzed retrospectively. The results were as follows: 1. According to the histological type, the malignant group and the benign group were divided into malignant group and benign group. The difference of each evaluation index between the two groups was compared, and the analysis was helpful in differentiating the MRI signs of benign and malignant tumors. The indicators included: sex, age, location, size, shape, MRI signal, boundary, growth pattern, peripheral tissue invasion, bone destruction, lymph node infiltration. Secondly, pleomorphic adenoma, basal cell adenoma, acinar cell carcinoma, mucoepidermoid carcinoma, squamous cell carcinoma, eosinophil carcinoma and lymphoma were compared with other tumors, and their supportive MRI findings were summarized. Results: first, the MRI signs for differential diagnosis of benign and malignant parotid gland were compared. The occurrence rate of the following signs in benign group was significantly higher than that in malignant group: high signal intensity in T2WI (P0. 004), homogeneous signal intensity in T2WI (P0. 023), clear boundary (p0. 001 before enhancement, P0. 000 after enhancement), obvious enhancement (P0. 000). Uniform strengthening (P0. 003). The occurrence rate of the following signs in malignant group was significantly higher than that in benign group: the tumor was located in the deep lobe (P0. 024, the accuracy of predicting malignancy was 70%), the signal of T2WI et al (P0. 024, accuracy of predicting malignancy was 67. 9%); Moderate enhancement (P0. 000, accuracy rate of predicting malignancy 69.7%), unclear boundary (before enhancement) (P0. 000, predictive accuracy of malignancy 72.7%), unclear boundary (after enhancement) (P0. 000, predictive accuracy of malignancy 70.9%); Subcutaneous tissue invasion (P0. 000, accuracy rate of predicting malignancy 87.2%), masticatory muscle / parapharyngeal space / facial nerve invasion (P0. 01, predictive accuracy of malignancy 76. 3%), lymph node invasion (P0. 000, predictive accuracy of malignancy 80%); T2WI was uneven (P0. 023, accuracy rate of predicting malignancy 41.8%) and non homogeneous enhancement (P0. 002, accuracy of predicting malignancy 46.7%). Tumor size, age, sex, lesion in left / right parotid lobe, lobulation, TIWI signal, low T2WI signal, mild enhancement, diffuse growth / single focus / multiple focus, unilateral / bilateral, translobar, cystic degeneration, accompanied by bone destruction. P > 0.05, the difference was not statistically significant. Second, supportive MR signs of different tumors. Pleomorphic adenoma was easy to occur in women, with clear boundary, high signal intensity of T2WI, obvious enhancement, and adenomatous lymphoma in male, located in superficial lobe, parotid gland tail, bilateral disease, multi-foci, homogeneous enhancement, moderate enhancement and clear boundary. Basal cell adenoma: surrounded by low signal ring with clear margin; acinar cell carcinoma: lobular, lymph node infiltration; mucoepidermoid carcinoma: lobular, unclear border, lymph node infiltration, cystic change; Squamous cell carcinoma: lobulated, subcutaneous infiltration, uneven TIVI signal; eosinophilic cell carcinoma: female, easily lobulated, deep lobes. Lymphoma: TIWI signal was uneven, moderately enhanced, invasion of masticatory muscle space / parapharyngeal infiltration, diffuse growth, unclear boundary. The occurrence rate of the above signs in the tumor group was significantly higher than that in the other tumor groups (P < 0.05). Conclusion: the tumor is located in deep lobes, with unclear boundary, T2WI signal, moderate enhancement, peripheral tissue and lymph node infiltration indicating parotid malignant tumor. Parotid pleomorphic adenoma, adenomatous lymphoma, basal cell adenocarcinoma, acinar cell carcinoma, mucoepidermoid carcinoma, squamous cell carcinoma, eosinophil carcinoma and lymphoma had corresponding supportive MRI signs.
【学位授予单位】:浙江大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:R445.2;R739.8
【相似文献】
相关期刊论文 前10条
1 黄发光,侯昌华,徐晓;腮腺肿瘤再次手术的临床原因分析[J];现代肿瘤医学;2003年02期
2 刘继延,赵文峰,陈增力,赵艳华;高频超声对腮腺肿瘤的检测价值[J];中国超声诊断杂志;2005年04期
3 周燕;毛维;宣吉晴;;实时超声对腮腺肿瘤的诊断价值[J];山西医药杂志;2006年10期
4 林阿平;;婴幼儿腮腺肿瘤144例特点分析[J];中国冶金工业医学杂志;2007年06期
5 金艳红;赵炳生;;腮腺切除治疗腮腺肿瘤45例报告[J];山东医药;2007年36期
6 董良峰;;腮腺肿瘤112例临床分析[J];新疆医学;2007年04期
7 李瑞春;刘婷;;273例腮腺肿瘤治疗的回顾性分析[J];中国社区医师(医学专业半月刊);2008年08期
8 张燕;张建丽;张晓芬;;高频超声诊断腮腺肿瘤的临床价值[J];现代实用医学;2008年04期
9 陈兴美;马彩叶;李星云;王肖琴;;高频超声在腮腺肿瘤中的诊断价值[J];现代中西医结合杂志;2008年19期
10 马征;黎春晖;赵威;付光新;王瑶;;保留腮腺功能的腮腺浅叶部分切除术[J];泸州医学院学报;2008年04期
相关会议论文 前10条
1 崔江涛;王东;彭诚;;天津317例腮腺肿物回顾性临床研究[A];中华口腔医学会全科口腔医学专业委员会第一次学术年会会议论文集[C];2009年
2 魏运辉;邓莅非;;腮腺肿瘤术后复发原因分析及再治疗探讨[A];第一届全国口腔颌面部肿瘤学术会议论文汇编[C];2001年
3 唐晓农;;89例腮腺肿瘤的临床分析[A];第一届全国口腔颌面部肿瘤学术会议论文汇编[C];2001年
4 公建平;;原发性腮腺肿瘤35例临床及病理分析[A];职工医院医学理论与实践[C];1998年
5 丁俊清;周海孝;;腮腺恶性肿瘤86例临床分析[A];第一届全国口腔颌面部肿瘤学术会议论文汇编[C];2001年
6 杨二虎;梁福英;;77例腮腺肿瘤的临床分析[A];第一届全国口腔颌面部肿瘤学术会议论文汇编[C];2001年
7 邹淑娟;陶阳;房居高;王超;;腮腺肿瘤的手术治疗76例回顾[A];第一届全国口腔颌面部肿瘤学术会议论文汇编[C];2001年
8 叶继胜;;21例腮腺肿瘤的螺旋CT回顾性分析[A];2005年浙江省放射学学术年会论文汇编[C];2005年
9 张悦萍;周根泉;张贵祥;;螺旋CT增强扫描在对腮腺肿瘤的诊断价值[A];2006年华东六省一市暨浙江省放射学学术年会论文汇编[C];2006年
10 金志勤;;腮腺肿瘤术后复发的部分专业原因[A];中华口腔医学会成立大会暨第六次全国口腔医学学术会议论文汇编[C];1996年
相关重要报纸文章 前3条
1 张志超;长时间手机贴耳打电话易得腮腺肿瘤是真的吗[N];河南科技报;2014年
2 屠规益;腮腺肿瘤应到口腔或头颈外科诊治[N];健康报;2005年
3 衡水市第四医院耳鼻咽喉——头颈外科副主任医师 曹文栋;耳垂下肿块巧识别[N];河北科技报;2003年
相关硕士学位论文 前10条
1 陈建端;51例腮腺肿瘤治疗的临床分析[D];吉林大学;2012年
2 袁虎威;潮汕地区腮腺肿瘤临床病理分析[D];汕头大学;2010年
3 Pranay Ranta Sakya;腮腺区域性切除术:耳后美容入路[D];大连医科大学;2008年
4 余韵;多层螺旋CT在鉴别腮腺良恶性肿瘤中的应用[D];安徽医科大学;2014年
5 段瑶;蜂窝式移动电话的使用与腮腺上皮源性肿瘤发病的相关性研究[D];中国人民解放军军医进修学院;2010年
6 李彦;3T MR三维稳态进动快速成像序列显示腮腺肿瘤及其与腮腺内面神经和腮腺导管的关系[D];山东大学;2010年
7 姚志涛;67例腮腺肿瘤的CT征象分析[D];新疆医科大学;2009年
8 李红;腮腺良恶性肿瘤鉴别诊断的MRI征象分析[D];浙江大学;2014年
9 杜燕飞;声辐射力脉冲成像及MR弥散张量成像在腮腺肿瘤中的诊断价值[D];山东大学;2014年
10 贺芬宜;MSCT双期增强扫描结合彩超对腮腺肿瘤的诊断价值研究[D];广西医科大学;2011年
,本文编号:2296359
本文链接:https://www.wllwen.com/yixuelunwen/fangshe/2296359.html